Skip to content

Investor Relations

Providing Transparent Financial
Information for Investors

IR Reports

IR Release

OCI IR ̼
No TITLE FILE DATE COUNT
103 Transition to a Holding Company FILE download 2022.11.23 381
102 Q3 2022 IR release (Reviewed by External Auditor) FILE download 2022.11.14 97
101 Q3 2022 IR release FILE download 2022.10.26 610
100 Q2 2022 IR release (Reviewed by External Auditor) FILE download 2022.08.12 155
99 Q2 2022 IR release FILE download 2022.07.26 2014
98 Q1 2022 IR release (Reviewed by External Auditor) FILE download 2022.05.13 165
97 Q1 2022 IR release FILE download 2022.04.28 462
96 Q4 2021 IR release (Reviewed by External Auditor) FILE download 2022.03.15 267
95 Notice of the Investment in Bukwang Pharmaceutical FILE download 2022.02.22 57
94 Q4 2021 IR release FILE download 2022.02.08 796
<< 1 2 3 4 5 6 7 8 9 10 1/11 >>
1 / 11

You may need to install Acrobat Reader to view PDF files

DOWNLOAD PDF VIEWER